Search

Search Results
Results 181 - 190 of 709 for Vaccines
  • BlueWillow Biologics
    Supplier Profile
    BlueWillow Biologics® is a clinical-stage biotechnology company that has developed a best-in-class, intranasal adjuvant and antigen delivery platform technology enabling a broad array of...
  • Xenocs SAS
    Supplier Profile
    Xenocs is a leading provider of X-ray scattering equipment (SAXS/WAXS) for nanoscale characterization of materials. These systems are essential for research, development, and production in a wide...
  • Microfluidic Cell-Squeezing Device Can Introduce Specific Antigens Inside Immune System’s B Cells
    News - 25 May 2015
    MIT researchers have shown that they can use a microfluidic cell-squeezing device to introduce specific antigens inside the immune system’s B cells, providing a new approach to developing and...
  • Nanovaccines: From Design to Characterization
    Article - 18 Jan 2023
    Learn about how nanovaccines are designed and eventually characterized in this article on AZoNano.
  • ETC Group
    Supplier Profile
    ETC Group is dedicated to the conservation and sustainable advancement of cultural and ecological diversity and human rights. To this end, ETC Group supports socially responsible developments of...
  • Happy Family Store
    Supplier Profile
    BioSante is developing a pipeline of hormone therapy products to treat both men and women. BioSante's hormone therapy products are gel formulations for transdermal administration that deliver...
  • Hybrid Membrane Personalized Nanovaccine may Overcome Tumor Recurrence and Metastasis Challenges
    News - 6 Aug 2021
    Thanks to the rapid development of nanotechnology, a research team led by Profs. NIE Guangjun, WU Yan and ZHAO Yuliang from the National Center for Nanoscience and Technology (NCNST) of the Chinese...
  • Pre-Clinical Data on Pregnant Baboons Immunized with Novavax RSV F Nanoparticle Vaccine Presented at 54th ICAAC
    News - 9 Sep 2014
    Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced pre-clinical...
  • NanoBio to Present Studies at ICAAC 2009
    News - 8 Sep 2009
    NanoBio Corp. announced today that data from a large ferret study indicates that its intranasal, nanoemulsion-based adjuvant elicits robust immunity and cross protection against influenza using 1/15th...
  • Merck
    Supplier Profile
    Our pursuit is progress for people everywhere. That's why we take a closer look at things, ask questions, and think ahead. We've been around for more than 350 years, yet our majority owners...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback